हिंदी में पढ़ें Zee Business हिंदी

Zydus Cadila

Zydus gets US regulator's PAS for generic version of Mycophenolate Mofetil for injection

Zydus gets US regulator's PAS for generic version of Mycophe...

Mon, Mar 21, 2022

The company said the PAS it has received is for site transfer into Jarod.

Zydus gets approval to conduct Phase II clinical study in patients with CAPS in Australia

Zydus gets approval to conduct Phase II clinical study in patient...

Mon, Dec 13, 2021

Drug firm Zydus Cadila on Monday said it has received approval to commence Phase II clinical study of its upcoming product with patients suffering with Cryopyrin-Associated Periodic Syndrome (CAPS) in Australia.

Zydus Cadila's Covid-19 vaccine ZyCoV-D to be used in these seven states initially

Zydus Cadila's Covid-19 vaccine ZyCoV-D to be used in these...

Thu, Dec 02, 2021

Zydus Cadila's COVID-19 vaccine ZyCoV-D will initially be used in seven states, including Maharashtra, Tamil Nadu, Uttar Pradesh and West Bengal, which have been recommended to identify the districts with a high number of of beneficiaries who have not received a single dose of a Covid vaccine for its introduction.

TRENDING NOW

Zydus Cadila gets USFDA nod to market generic cancer drug in US

Zydus Cadila gets USFDA nod to market generic cancer drug in US

Sat, Nov 20, 2021

The company has received final approval from the US Food and Drug Administration (USFDA) to Decitabine for Injection in the strength of 50 mg/vial single-dose vial, Zydus Cadila said in a statement

Zydus Cadila agrees to reduce its Covid vaccine price to Rs 265 a dose, final decision soon: Sources

Zydus Cadila agrees to reduce its Covid vaccine price to Rs 265 a...

Sun, Oct 31, 2021

Zydus Cadila has agreed to bring down the price of its COVID-19 vaccine to Rs 265 a dose following persistent negotiations by the government but a final deal is yet to be reached, sources said on S

Cadila Healthcare Q2 profit zooms over 6-fold to Rs 3,002 crore on one-time gain

Cadila Healthcare Q2 profit zooms over 6-fold to Rs 3,002 crore o...

Fri, Oct 29, 2021

Drug firm Cadila Healthcare on Monday reported an over six-fold jump in its consolidated net profit to Rs 3,002.3 crore for the quarter ended September 30, 2021

Zydus Cadila vaccine: ZyCoV-D LAUNCH in September! PRICE not finalised, aims to produce 5 cr doses by January 2022, says MD Sharvil Patel

Zydus Cadila vaccine: ZyCoV-D LAUNCH in September! PRICE not fina...

Sat, Aug 21, 2021

Zydus Cadila ZyCoV-D vaccine: The vaccine will be administered in 3-dose and work on even Children and adults of age 12 years and above.

Zydus Cadila vaccine for Covid 19: World's first DNA-based vaccine! What we know so far about 3-DOSE vaccine that can be administered to children aged 12 years and above too

Zydus Cadila vaccine for Covid 19: World's first DNA-based v...

Sat, Aug 21, 2021

Covid 19 new vaccine: The world’s first and India’s indigenously developed DNA based vaccine for COVID-19 will be administered in 3-dose.

COVID-19 Vaccine India Update: After Johnson & Johnson, Zydus LIKELY to be APPROVED for use by THIS WEEK - check details

COVID-19 Vaccine India Update: After Johnson & Johnson, Zydus...

Mon, Aug 09, 2021

After Johnson and Johnson single dose COVID-19 vaccine, Zydus vaccine may get the approval for use in India by this week

'Investment of Rs 3K-5K cr needed to create extra mfg facilities for COVID-19 vaccine'

'Investment of Rs 3K-5K cr needed to create extra mfg facili...

Tue, Sep 22, 2020

As the world waits expectantly for COVID-19 vaccine, Zydus Cadila Chairman Pankaj R Patel said India would need to invest between Rs 3,000-5,000 crore to create additional facilities for making a huge number of vaccines required for the Indian population

After Bharat Biotech, Zydus COVID-19 vaccine candidate gets nod from Centre for human trials

After Bharat Biotech, Zydus COVID-19 vaccine candidate gets nod f...

Fri, Jul 03, 2020

The potential vaccine showed a "strong immune response" in animal studies, and the antibodies produced were able to completely neutralize the wild type virus, Zydus, part of Cadila Healthcare Ltd, said in a statement to Indian stock exchanges.

Zydus Cadila gets tentative nod from US health regulator to market type-2 diabetes drug

Zydus Cadila gets tentative nod from US health regulator to marke...

Sat, May 02, 2020

Drug firm Zydus Cadila on Saturday said it has received tentative nod from the US health regulator to market generic Empagliflozin and Metformin Hydrochloride tablets, used for management of type-2 diabetes, in the American market.

Zydus receives tentative approval from USFDA for Tofacitinib tablets

Zydus receives tentative approval from USFDA for Tofacitinib tabl...

Sat, Apr 06, 2019

Tofacitinib is used alone or with other medications to treat moderate to severe forms of rheumatoid arthritis, the company said in a BSE filing.

Zydus Cadila gets USFDA nod to market Potassium Chloride capsules

Zydus Cadila gets USFDA nod to market Potassium Chloride capsules

Wed, Mar 13, 2019

The company has more than 254 approvals and has so far filed over 350 abbreviated new drug applications (ANDAs) since it commenced filings in 2003-04.

Market Opening: Sensex rises 200 pts, Nifty by 60 pts on the last day of 2018

Market Opening: Sensex rises 200 pts, Nifty by 60 pts on the last...

Mon, Dec 31, 2018

Bank Nifty opened in the green at Rs 27,260, up by 135 points. Crude was stable and closed at $52.25 per barrel on Friday. Indian rupee appreciated by 14 paise to Rs 69.8 per dollar.

Zydus Wellness rises over 4% as CCI clears deal with Heinz India

Zydus Wellness rises over 4% as CCI clears deal with Heinz India

Wed, Dec 12, 2018

Shares of Zydus Wellness surged over 4 per cent Wednesday as the CCI approved Zydus Cadila's deal to acquire Heinz India's consumer wellness business.

Zydus Cadila gets USFDA nod to market generic HIV treatment tablets

Zydus Cadila gets USFDA nod to market generic HIV treatment table...

Fri, Nov 16, 2018

Drug firm Zydus Cadila Friday said it has received final approval from the US health regulator to market generic Abacavir and Lamivudine tablets used for treatment of a type of HIV infection.

Zydus Cadila gets USFDA nod to market Doxazosin tablets

Zydus Cadila gets USFDA nod to market Doxazosin tablets

Sat, Jul 08, 2017

The group now has more than 120 approvals and has so far filed over 300 abbreviated new drug applications (ANDAs), it added.

NPPA reduces prices of essential drugs by more than 50% in March-Oct 2016

NPPA reduces prices of essential drugs by more than 50% in March-...

Tue, Mar 07, 2017

NPPA on Tuesday tweeted list of 23 essential medicines under NLEM 2015 of which prices were reduced for more than 50% from March to October 2016.

Zydus Cadila acquires six brands from American pharma MSD

Zydus Cadila acquires six brands from American pharma MSD

Wed, Dec 28, 2016

Though the companies have not disclosed the financial details of the deal.

WATCH: Top 5 stories of this evening; From fall in markets on profit booking to Govt appointing Viral Acharya as RBI's new deputy governor

WATCH: Top 5 stories of this evening; From fall in markets on pro...

Wed, Dec 28, 2016

Zee Business brings you the most important stories of the day that will help you shape your market strategies and keep you informed with the latest developments.

WATCH: Top 5 stories of this afternoon; From NSE Nifty nearing 8,050-mark to NITI Aayog suggesting 7% custom duty on manufacturing

WATCH: Top 5 stories of this afternoon; From NSE Nifty nearing 8,...

Wed, Dec 28, 2016

Zee Business brings you the most important stories of the day that will help you shape your market strategies and keep you informed with the latest developments.

Zydus Cadila can launch ulcer drug in US, patent litigation settled

Zydus Cadila can launch ulcer drug in US, patent litigation settl...

Sat, Dec 03, 2016

Drug firm Zydus Cadila on Saturday said the patent litigation relating to Allergan's Delzicol, used to treat ulcerative colitis, has been settled.

Load More

LIVE TV

By accepting cookies, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts.

x